Iris Parent Holding CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Samda Biolab Co., Ltd. has reported beneficial ownership of 3,426,548 shares, representing 5.1% of Liminatus Pharma, Inc.'s common stock.
NASDAQ
Ewon Comfortech Co., Ltd. has reported beneficial ownership of 5,500,000 shares, representing 10.9% of Liminatus Pharma, Inc.'s common stock, as of June 24, 2026.
NASDAQ
KH Feelux Co., Ltd has disclosed a significant 15.4% beneficial ownership stake in Liminatus Pharma, Inc., holding 4,000,000 shares of common stock.
NASDAQ
Red Peony Association 1st has reported a beneficial ownership of 5.7% in Liminatus Pharma, Inc., holding 1,470,000 shares of common stock.
NASDAQ
SCHEDULE 13G: Ewon Comfortech Discloses 5.8% Stake in Liminatus Pharma Following Business Combination
Ewon Comfortech Co., Ltd. has disclosed a 5.8% beneficial ownership stake in Liminatus Pharma, Inc., holding 1,500,000 shares of common stock following the consummation of a business combination on April 30, 2025.
NASDAQ
Nongae Apple Association 1st has reported a 5.7% passive ownership stake in Liminatus Pharma, Inc. following the consummation of a business combination.